Neurotransmitter receptor density changes in Pitx3ak mice - A model relevant to Parkinson's disease

Cremer, Jennifer; Graw, J.; Rösch, F.; Amunts, K.; Zilles, K.; Piel, M.

doi:10.1016/j.neuroscience.2014.10.050

Typ	Amount	VAT	Currency	Share	Status	Cost centre
Colour charges	295.00	0.00	EUR	100.00 %	(Zahlung erfolgt)	ZB
Sum	295.00	0.00	EUR
Total	295.00

Journal Article

FZJ-2014-06294

Neurotransmitter receptor density changes in Pitx3ak mice - A model relevant to Parkinson's disease

Cremer, J. (Corresponding Author)FZJ* ; Amunts, K.FZJ* ; Graw, J. ; Piel, M. ; Rösch, F. ; Zilles, K.FZJ*

2015
Elsevier Science Amsterdam [u.a.]

Neuroscience 285, 11–23 (2015) [10.1016/j.neuroscience.2014.10.050]

This record in other databases:

Please use a persistent id in citations: doi:10.1016/j.neuroscience.2014.10.050

Abstract: Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by alterations of nigrostriatal dopaminergic neurotransmission. Compared to the wealth of data on the impairment of the dopamine system, relatively limited evidence is available concerning the role of major non-dopaminergic neurotransmitter systems in PD.Therefore, we comprehensively investigated the density and distribution of neurotransmitter receptors for glutamate, GABA, acetylcholine, adrenaline, serotonin, dopamine and adenosine in brains of homozygous aphakia mice being characterized by mutations affecting the Pitx3 gene. This genetic model exhibits crucial hallmarks of PD on the neuropathological, symptomatic and pharmacological level. Quantitative receptor autoradiography was used to characterize 19 different receptor binding sites in eleven brain regions in order to understand receptor changes on a systemic level.We demonstrated striking differential changes of neurotransmitter receptor densities for numerous receptor types and brain regions, respectively. Most prominent, a strong up-regulation of GABA receptors and associated benzodiazepine binding sites in different brain regions and concomitant down-regulations of striatal nicotinic acetylcholine and serotonergic receptor densities were found. Furthermore, the densities of glutamatergic kainate, muscarinic acetylcholine, adrenergic α1 and dopaminergic D2/D3 receptors were differentially altered.These results present novel insights into the expression of neurotransmitter receptors in Pitx3ak mice supporting findings on PD pathology in patients and indicating on the possible underlying mechanisms. The data suggest Pitx3ak mice as an appropriate new model to investigate the role of neurotransmitter receptors in PD. Our study highlights the relevance of non-dopaminergic systems in PD and for the understanding of its molecular pathology.

Classification: